Clinical Trial Update: Study to Evaluate Safety and Tolerability of BF-200 ALA (Ameluz®) for Photodynamic Therapy in the Treatment of the Expanded Field of Actinic Keratosis on Face and Scalp [Phase 1]

View source ↗

Summary

Phase 1 study evaluating safety and tolerability of BF-200 ALA (Ameluz) for photodynamic therapy in the expanded field of actinic keratosis on the face and scal…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Keratosis

Drugs mentioned

• AMELUZ (AMINOLEVULINIC ACID HYDROCHLORIDE)

Snippet

Sponsor: Biofrontera Bioscience GmbH | Conditions: Actinic Keratosis, Keratosis, Actinic | Phase 1 | Status: COMPLETED | Results posted: 2024-10-17